Source disclosure: February 10, 2026
YOMEISHU SEIZO CO.,LTD. [2540.T]
TOKYO, Feb 10 (Pulse News Wire) – Yomeishu Seizo CO.,LTD. (2540.T) decided to tender its entire holding of 101,000 ordinary shares in Koyu Pharmaceutical Co., Ltd.
In response to a public offer initiated by Taiyo Sangyo Co., Ltd. The tender is expected to result in a special gain of ¥1.489 billion as investment securities sale profit for the fiscal year ending March 2026. The decision was made after considering various factors, including the approval of Koyu Pharmaceutical's board of directors and the deemed reasonable conditions of the buyout price.
The public offering began on January 07, 2026, and the tendering period ended on February 19, 2026. Settlement is scheduled to commence on February 27, 2026. Following the completion of the transaction, Yomeishu Seizo expects to record a special gain of ¥1.489 billion as investment securities sale profit for the fiscal year ending March 2026.
However, since the projected earnings forecast for the same period already includes the anticipated gains from the policy shareholding disposal, there will be no changes to the current performance outlook.
AI-translated content. 🟢 Confidence: High See terms • Original filing